HCA Healthcare, Inc. Annual Report, Year Ended Dec 31, 2025

HCA Healthcare, Inc. (HCA) reported strong financial performance for the fiscal year ended December 31, 2025, with revenues increasing to $75.6 billion, a 7.1% rise year-over-year. Net income attributable to HCA Healthcare, Inc. also saw a significant increase, reaching $6.784 billion, up from $5.760 billion in the prior year. This growth was driven by a combination of increased patient volumes, evidenced by a 2.9% rise in equivalent admissions, and an improved revenue per equivalent admission of 4.0%. The company continues to execute its growth strategy, focusing on expanding its presence in existing markets, enhancing operational excellence, and investing in digital and AI capabilities to drive efficiency and improve patient care. Despite a challenging macroeconomic environment marked by inflationary pressures and increasing labor costs, HCA Healthcare demonstrated resilience. The company's strategic investments in its workforce and operational efficiency have helped mitigate some of these pressures. Management remains focused on long-term value creation for stockholders, supported by ongoing share repurchase programs and a consistent dividend. Key risks to monitor include the evolving regulatory landscape, labor market dynamics, and cybersecurity threats, all of which the company actively manages.